AXON Stock Analysis: Axon Enterprise | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 25.686m USD | 12M Return: -43.7% | US05464C1018 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 486M
EPS Trend: 53.9%
Qual. Beats: 0
Rev. Trend: 100.0%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Axon Enterprise, Inc. (NASDAQ: AXON) is a U.S.-based public safety technology company headquartered in Scottsdale, Arizona, operating through two main segments: Software and Services, and Connected Devices. The Software and Services segment offers cloud-based SaaS platforms for capturing, storing, and analyzing digital evidence, including products such as Axon Evidence, Draft One, Axon Records, and Axon Fusus. The Connected Devices segment produces hardware such as TASER conducted energy devices, body-worn and in-car cameras, drone and counter-drone systems, and virtual reality training equipment.
The company sells to a diverse customer base that includes federal, state, and local law enforcement agencies, international government entities, commercial enterprises, and consumers, using a mix of direct sales, distribution partners, and third-party resellers. Originally incorporated in 1993 and formerly known as TASER International, the company rebranded to Axon Enterprise in April 2017 to reflect its expansion beyond conducted energy weapons into a broader integrated software and hardware ecosystem for first responders.
Axon is classified under the GICS Industrials sector and Aerospace & Defense sub-industry, though its primary end market is law enforcement and public safety rather than traditional military defense. A key feature of its business model is the recurring revenue generated through its SaaS subscriptions and evidence-management platforms, which complement the one-time hardware sales of TASER devices and cameras and support customer retention across agency lifecycles.
- Software and Services segment drives recurring revenue growth
- TASER and body camera demand strengthens from US law enforcement
- International expansion and drone counter-drone adoption accelerate
- Federal and state government budget cycles impact order timing
| Net Income: 258.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.26 > 1.0 |
| NWC/Revenue: 83.56% < 20% (prev 112.1%; Δ -28.52% < -1%) |
| CFO/TA 0.03 > 3% & CFO 225.5m > Net Income 258.7m |
| Net Debt (1.41b) to EBITDA (564.7m): 2.51 < 3 |
| Current Ratio: 3.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (83.7m) vs 12m ago 6.70% < -2% |
| Gross Margin: 58.53% > 18% (prev 60.31%; Δ -1.78% > 0.5%) |
| Asset Turnover: 44.12% > 50% (prev 38.42%; Δ 5.70% > 0%) |
| Interest Coverage Ratio: 3.78 > 6 (EBIT TTM 430.7m / Interest Expense TTM 113.9m) |
| A: 0.32 (Total Current Assets 4.28b - Total Current Liabilities 1.43b) / Total Assets 8.83b |
| B: 0.13 (Retained Earnings 1.19b / Total Assets 8.83b) |
| C: 0.06 (EBIT TTM 430.7m / Avg Total Assets 7.75b) |
| D: 0.74 (Book Value of Equity 3.76b / Total Liabilities 5.07b) |
| Altman-Z'' = 3.71 = AA |
| DSRI: 0.90 (Receivables 838.3m/700.7m, Revenue 3.42b/2.56b) |
| GMI: 1.03 (GM 60.31% / 58.53%) |
| AQI: 1.46 (AQ_t 0.47 / AQ_t-1 0.32) |
| SGI: 1.34 (Revenue 3.42b / 2.56b) |
| TATA: 0.00 (NI 258.7m - CFO 225.5m) / TA 8.83b) |
| Beneish M = -2.57 (Cap -4..+1) = A |
As of November 19, 2026, the stock is trading at USD 300.69 with a total of 1,208,086 shares traded. Over the past week, the price has changed by -4.67%, over one month by -21.51%, over three months by -51.49% and over the past year by -43.67%.
Current recommended Stop Loss: 276.50 (which is 8% or 1.1 ATR below the current price).
Axon Enterprise has received a consensus analysts rating of 4.29. Therefore, it is recommended to buy AXON.
- StrongBuy: 9
- Buy: 9
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 541.3 | 80% |
P/E Trailing = 101.4244
P/E Forward = 58.1395
P/S = 7.5172
P/B = 10.1547
P/EG = 2.1074
Revenue TTM = 3.42b USD
EBIT TTM = 430.7m USD
EBITDA TTM = 564.7m USD
Long Term Debt = 2.87b USD (from longTermDebt, last quarter)
Short Term Debt = 80.6m USD (from shortTermDebt, last fiscal year)
Debt = 3.07b USD (from shortLongTermDebtTotal, last quarter) + Leases 100.9m
Net Debt = 1.41b USD (calculated: Debt 3.07b - CCE 1.66b)
Enterprise Value = 27.1b USD (25.7b + Debt 3.07b - CCE 1.66b)
Interest Coverage Ratio = 3.78 (Ebit TTM 430.7m / Interest Expense TTM 113.9m)
EV/FCF = 334.9x (Enterprise Value 27.1b / FCF TTM 80.9m)
FCF Yield = 0.30% (FCF TTM 80.9m / Enterprise Value 27.1b)
FCF Margin = 2.37% (FCF TTM 80.9m / Revenue TTM 3.42b)
Net Margin = 7.57% (Net Income TTM 258.7m / Revenue TTM 3.42b)
Gross Margin = 58.53% ((Revenue TTM 3.42b - Cost of Revenue TTM 1.42b) / Revenue TTM)
Gross Margin QoQ = 56.68% (prev 60.42%)
Tobins Q-Ratio = 3.07 (Enterprise Value 27.1b / Total Assets 8.83b)
Interest Expense / Debt = 3.71% (Interest Expense 113.9m / Debt 3.07b)
Taxrate = 18.33% (58.1m / 316.8m)
NOPAT = 351.8m (EBIT 430.7m * (1 - 18.33%))
Current Ratio = 3.00 (Total Current Assets 4.28b / Total Current Liabilities 1.43b)
Debt / Equity = 0.82 (Debt 3.07b / totalStockholderEquity, last quarter 3.76b)
Debt / EBITDA = 2.51 (Net Debt 1.41b / EBITDA 564.7m)
Debt / FCF = 17.48 (Net Debt 1.41b / FCF TTM 80.9m)
Total Stockholder Equity = 3.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.34% (Net Income 258.7m / Total Assets 8.83b)
RoE = 7.28% (Net Income TTM 258.7m / Total Stockholder Equity 3.55b)
RoCE = 6.71% (EBIT 430.7m / Capital Employed (Equity 3.55b + L.T.Debt 2.87b))
RoIC = 4.81% (NOPAT 351.8m / Invested Capital 7.32b)
WACC = 9.42% (E(25.7b)/V(28.8b) * Re(10.18%) + D(3.07b)/V(28.8b) * Rd(3.71%) * (1-Tc(0.18)))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 41.44 | Cagr: 3.44%
[DCF] Terminal Value 69.21% ; FCFF base≈106.6m ; Y1≈93.4m ; Y5≈75.5m
[DCF] Fair Price = N/A (negative equity: EV 1.03b - Net Debt 1.41b = -383.8m; debt exceeds intrinsic value)
EPS Correlation: 53.89 | EPS CAGR: 12.81% | SUE: -0.42 | # QB: 0
Revenue Correlation: 99.99 | Revenue CAGR: 33.17% | SUE: -2.16 | # QB: -1
EPS current Quarter (2027-03-31): EPS=1.93 | Chg30d=-12.37% | Revisions=-77% | Analysts=16
EPS current Year (2026-12-31): EPS=7.11 | Chg30d=-7.04% | Revisions=-47% | GrowthEPS=+3.8% | GrowthRev=+30.4%
EPS next Year (2027-12-31): EPS=9.44 | Chg30d=-10.43% | Revisions=-71% | GrowthEPS=+32.9% | GrowthRev=+27.5%
[Analyst] Revisions Ratio: -73% (up=4, down=34)